Introduction Chronic kidney disease (CKD) is associated with an increased risk of
cardiovascular disease and mortality, which is thought to be caused by increased propensity …

Background Elevated levels of serum magnesium are associated with lower risk of
cardiovascular events in patients with CKD. Magnesium also prevents vascular calcification …

Vascular calcification (VC) is associated with elevated cardiovascular mortality rates in
patients with CKD. Recent clinical studies of patients with advanced CKD have observed an …

Purpose To evaluate the effects of magnesium (Mg) supplementation on vascular
calcification (VC) in patients with chronic kidney disease (CKD). Methods PubMed, Embase …

Background: Arteriosclerosis and cardiovascular disease are strongly associated with
vascular calcification. Hyperphosphatemia is an essential risk factor for increased vascular …

Cardiovascular complications are the leading cause of death in patients with chronic kidney
disease (CKD). Abundant experimental evidence suggests a physiological role of …

Patients with chronic kidney disease (CKD) have a high prevalence of vascular calcification,
and cardiovascular disease is the leading cause of death in this population. However, the …

Introduction Chronic kidney disease (CKD) is associated with high cardiovascular morbidity
and mortality. Recent evidence suggests that increases in both serum and intracellular …

Magnesium (Mg) is one of the most important cations in the body, playing an essential role
in biological systems as co-factor for more than 300 essential enzymatic reactions. In the …

Vascular calcification is a serious complication of chronic kidney disease, but the current
therapeutic strategy is insufficient for preventing its progression. Magnesium is a potent …